NORTHBROOK, Ill.--(BUSINESS WIRE)--Intelligent Medical Objects, Inc. (IMO), developer of the most-widely used and physician-preferred terminology service for electronic health records (EHR) systems, announces the appointment of Dan Watanapongse to serve as EVP and Chief Financial Officer of IMO. Dan brings over 20 years of experience leading global finance teams and a business partnership mindset to drive growth and performance.
“I am excited to bring the caliber of executive talent and private equity experience that Dan has to our company,” said Frank Naeymi-Rad, PhD, MBA, Chairman and Chief Executive Officer of IMO. “His ability to work with our team to continue our company’s growth trajectory through sustainable process improvement and mergers and acquisitions experience will build upon our strong foundation”.
“I am honored to join the IMO family,” said Mr. Watanapongse. “We have a great business that uniquely serves healthcare providers with a trusted terminology platform that enhances the delivery of care and positively impacts patients, medical professionals and healthcare organizations around the world”
Dan most recently served as SVP and Chief Financial Officer of Sterigenics International, the leading global provider of contract sterilization, lab services, gamma technologies and medical isotopes, a portfolio company of Warburg Pincus and GTCR. Prior to Sterigenics, Dan has held various leadership roles of increasing responsibility with Sears Holdings, Bosch and SPX. Before SPX, Dan worked at Deloitte and Arthur Andersen in the M&A and Audit service lines. Dan holds a bachelor’s degree from Indiana University and is a Certified Public Accountant.
About IMO
Intelligent Medical Objects, Inc. (IMO), is the developer of the most widely-accepted medical terminology solution for the management of medical vocabularies and software applications at healthcare organizations worldwide. IMO’s terminology is used by more than 4,500 hospitals and 450,000 physicians daily, and this trusted terminology platform supports innovations by provider systems. IMO medical vocabulary and mapping products effectively capture clinical intent and help EMRs preserve and communicate this across the entire spectrum of care. IMO clinical terms are mapped to all standard coding systems including ICD-9, ICD-10, and SNOMED®. The accuracy of IMO’s interface terminology was found to be “nearly perfect” in an independent study published by the US Centers for Disease Control. In 2016, IMO received a growth capital investment from Warburg Pincus, a global private equity firm focused on growth investing. Read more at www.e-imo.com.
Back to HCB News
